Tag: major depressive disorder

Definium Therapeutics (NASDAQ: DFTX) is set to present findings from three positive Phase 3 clinical trials of its LSD-based drug ...

The US pharmaceutical giant has put $906 million behind a next-generation psychedelic for depression, giving one of the industry’s largest ...

Optimi Health has completed production of a new batch of 5mg naturally derived psilocybin capsules, with the same batch set ...

LSD has moved a significant step closer to becoming an approved prescription medicine after Definium Therapeutics reported positive topline results ...